Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal

The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate resp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience 2002-01, Vol.112 (3), p.605-617
Hauptverfasser: McNally, G.P, Akil, H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 617
container_issue 3
container_start_page 605
container_title Neuroscience
container_volume 112
creator McNally, G.P
Akil, H
description The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal. Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone. In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH 9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH 9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH 9–41 were without effect. These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors.
doi_str_mv 10.1016/S0306-4522(02)00105-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18473271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306452202001057</els_id><sourcerecordid>18473271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</originalsourceid><addsrcrecordid>eNqFkd2KFDEQhRtR3HH1EZTcKArbmnQ6ne4rkcU_WBD8uQ7VSfVOJJ2MSXqXeS5f0PTM6F4aAoHKV6cOdarqKaOvGWXdm2-U065uRdO8pM0rShkVtbxXbVgveS1F296vNv-Qs-pRSj9pOaLlD6sz1lDZDrTZVL-_BockTESHmK0OOYad9XVEh5CsvybbEOfgkVhP8hYJzPtrAw4IeENGNMQv2uGSVon1P-VogWSMs_XgbPrbN-IWbmyI4C7IDkpxDmZxkEPcXxy00Jugoy2TdPAJfy3oNR5kiyHISG5t3poIt-AeVw8mcAmfnN7z6seH998vP9VXXz5-vnx3VWvRiVxDQwdmqBZTN05Dp800DJPsKJsMlU0nexDYC9E2rBskb8U4CjH2vOfdCB3vKT-vXhx1dzEUPymr2SaNzoHHsCTF-lbyRrICiiOoY0gp4qR20c4Q94pRtaalDmmpNQpFy13TUrL0PTsNWMYZzV3XKZ4CPD8BkDS4KYLXNt1xXHIp6VC4t0cOyzpuLEaVtF0XaGxEnZUJ9j9W_gBUPLRZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18473271</pqid></control><display><type>article</type><title>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>McNally, G.P ; Akil, H</creator><creatorcontrib>McNally, G.P ; Akil, H</creatorcontrib><description>The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal. Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone. In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH 9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH 9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH 9–41 were without effect. These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/S0306-4522(02)00105-7</identifier><identifier>PMID: 12074902</identifier><identifier>CODEN: NRSCDN</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Amygdala - physiopathology ; Animals ; anxiety ; Behavior, Animal - physiology ; Behavioral psychophysiology ; Biological and medical sciences ; Corticotropin-Releasing Hormone - administration &amp; dosage ; Corticotropin-Releasing Hormone - genetics ; Corticotropin-Releasing Hormone - metabolism ; Corticotropin-Releasing Hormone - pharmacology ; drug dependence ; Endocrine Glands - physiopathology ; fear ; Fundamental and applied biological sciences. Psychology ; Hormones and behavior ; Humans ; hyperalgesia ; in situ hybridization ; Injections ; Injections, Intraventricular ; Male ; Morphine - adverse effects ; Naloxone - pharmacology ; Narcotic Antagonists - pharmacology ; Narcotics - adverse effects ; Pain - physiopathology ; Peptide Fragments - administration &amp; dosage ; Peptide Fragments - pharmacology ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Rats ; Rats, Sprague-Dawley ; RNA, Messenger - metabolism ; Septal Nuclei - physiopathology ; stress ; Substance Withdrawal Syndrome - physiopathology ; Substance Withdrawal Syndrome - psychology</subject><ispartof>Neuroscience, 2002-01, Vol.112 (3), p.605-617</ispartof><rights>2002 IBRO</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</citedby><cites>FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0306452202001057$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13737709$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12074902$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McNally, G.P</creatorcontrib><creatorcontrib>Akil, H</creatorcontrib><title>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal. Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone. In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH 9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH 9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH 9–41 were without effect. These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors.</description><subject>Amygdala - physiopathology</subject><subject>Animals</subject><subject>anxiety</subject><subject>Behavior, Animal - physiology</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Corticotropin-Releasing Hormone - administration &amp; dosage</subject><subject>Corticotropin-Releasing Hormone - genetics</subject><subject>Corticotropin-Releasing Hormone - metabolism</subject><subject>Corticotropin-Releasing Hormone - pharmacology</subject><subject>drug dependence</subject><subject>Endocrine Glands - physiopathology</subject><subject>fear</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hormones and behavior</subject><subject>Humans</subject><subject>hyperalgesia</subject><subject>in situ hybridization</subject><subject>Injections</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Morphine - adverse effects</subject><subject>Naloxone - pharmacology</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Narcotics - adverse effects</subject><subject>Pain - physiopathology</subject><subject>Peptide Fragments - administration &amp; dosage</subject><subject>Peptide Fragments - pharmacology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>RNA, Messenger - metabolism</subject><subject>Septal Nuclei - physiopathology</subject><subject>stress</subject><subject>Substance Withdrawal Syndrome - physiopathology</subject><subject>Substance Withdrawal Syndrome - psychology</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2KFDEQhRtR3HH1EZTcKArbmnQ6ne4rkcU_WBD8uQ7VSfVOJJ2MSXqXeS5f0PTM6F4aAoHKV6cOdarqKaOvGWXdm2-U065uRdO8pM0rShkVtbxXbVgveS1F296vNv-Qs-pRSj9pOaLlD6sz1lDZDrTZVL-_BockTESHmK0OOYad9XVEh5CsvybbEOfgkVhP8hYJzPtrAw4IeENGNMQv2uGSVon1P-VogWSMs_XgbPrbN-IWbmyI4C7IDkpxDmZxkEPcXxy00Jugoy2TdPAJfy3oNR5kiyHISG5t3poIt-AeVw8mcAmfnN7z6seH998vP9VXXz5-vnx3VWvRiVxDQwdmqBZTN05Dp800DJPsKJsMlU0nexDYC9E2rBskb8U4CjH2vOfdCB3vKT-vXhx1dzEUPymr2SaNzoHHsCTF-lbyRrICiiOoY0gp4qR20c4Q94pRtaalDmmpNQpFy13TUrL0PTsNWMYZzV3XKZ4CPD8BkDS4KYLXNt1xXHIp6VC4t0cOyzpuLEaVtF0XaGxEnZUJ9j9W_gBUPLRZ</recordid><startdate>20020101</startdate><enddate>20020101</enddate><creator>McNally, G.P</creator><creator>Akil, H</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope></search><sort><creationdate>20020101</creationdate><title>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</title><author>McNally, G.P ; Akil, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-a2091d0c5f6bf96cdf99f7601fd072678a5e855421697345bb55b83836ba63803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Amygdala - physiopathology</topic><topic>Animals</topic><topic>anxiety</topic><topic>Behavior, Animal - physiology</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Corticotropin-Releasing Hormone - administration &amp; dosage</topic><topic>Corticotropin-Releasing Hormone - genetics</topic><topic>Corticotropin-Releasing Hormone - metabolism</topic><topic>Corticotropin-Releasing Hormone - pharmacology</topic><topic>drug dependence</topic><topic>Endocrine Glands - physiopathology</topic><topic>fear</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hormones and behavior</topic><topic>Humans</topic><topic>hyperalgesia</topic><topic>in situ hybridization</topic><topic>Injections</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Morphine - adverse effects</topic><topic>Naloxone - pharmacology</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Narcotics - adverse effects</topic><topic>Pain - physiopathology</topic><topic>Peptide Fragments - administration &amp; dosage</topic><topic>Peptide Fragments - pharmacology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>RNA, Messenger - metabolism</topic><topic>Septal Nuclei - physiopathology</topic><topic>stress</topic><topic>Substance Withdrawal Syndrome - physiopathology</topic><topic>Substance Withdrawal Syndrome - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McNally, G.P</creatorcontrib><creatorcontrib>Akil, H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McNally, G.P</au><au>Akil, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2002-01-01</date><risdate>2002</risdate><volume>112</volume><issue>3</issue><spage>605</spage><epage>617</epage><pages>605-617</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><coden>NRSCDN</coden><abstract>The extra-hypothalamic actions of corticotropin-releasing hormone (CRH) have been accorded an important role in coordinating responses to stressors and contributing to the consequences of drug abuse. Recent proposals suggest that CRH actions in the bed nucleus of the stria terminalis coordinate responses to tonic/unpredictable stressors whereas these actions in the central nucleus of the amygdala coordinate responses to phasic/predictable stressors. We used in situ hybridization histochemistry and site-specific microinjections of a CRH receptor antagonist to study the role of CRH in opiate withdrawal. Rats undergoing opiate withdrawal displayed clear behavioral and autonomic changes accompanied by hyperalgesia and increased plasma corticosterone. In situ hybridization of CRH mRNA revealed significant increases in the central nucleus of the amygdala but not in the bed nucleus of the stria terminalis among rats either chronically pre-treated with morphine, given an injection of naloxone, or both (precipitated withdrawal). An increase of CRH mRNA in the paraventricular nucleus of the hypothalamus was specific to rats undergoing withdrawal. Intracerebroventricular microinjection of the CRH receptor antagonist, αhCRH 9–41, reduced the severity of opiate withdrawal. Microinjections of αhCRH 9–41 into the central nucleus of the amygdala also reduced the severity of withdrawal whereas bed nucleus of the stria terminalis microinjections of αhCRH 9–41 were without effect. These experiments provide evidence for a role of amygdala, but not bed nucleus of the stria terminalis, CRH in opiate dependence. We propose a specific role for down-regulation of opiate receptor signaling in increased expression of the CRH gene in the amygdala. Moreover, we suggest that the roles accorded to CRH in the bed nucleus of the stria terminalis versus amygdala in coordinating responses to stressors may need to be reconsidered to distinguish between external and internal/interoceptive stressors.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12074902</pmid><doi>10.1016/S0306-4522(02)00105-7</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4522
ispartof Neuroscience, 2002-01, Vol.112 (3), p.605-617
issn 0306-4522
1873-7544
language eng
recordid cdi_proquest_miscellaneous_18473271
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amygdala - physiopathology
Animals
anxiety
Behavior, Animal - physiology
Behavioral psychophysiology
Biological and medical sciences
Corticotropin-Releasing Hormone - administration & dosage
Corticotropin-Releasing Hormone - genetics
Corticotropin-Releasing Hormone - metabolism
Corticotropin-Releasing Hormone - pharmacology
drug dependence
Endocrine Glands - physiopathology
fear
Fundamental and applied biological sciences. Psychology
Hormones and behavior
Humans
hyperalgesia
in situ hybridization
Injections
Injections, Intraventricular
Male
Morphine - adverse effects
Naloxone - pharmacology
Narcotic Antagonists - pharmacology
Narcotics - adverse effects
Pain - physiopathology
Peptide Fragments - administration & dosage
Peptide Fragments - pharmacology
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Rats
Rats, Sprague-Dawley
RNA, Messenger - metabolism
Septal Nuclei - physiopathology
stress
Substance Withdrawal Syndrome - physiopathology
Substance Withdrawal Syndrome - psychology
title Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20corticotropin-releasing%20hormone%20in%20the%20amygdala%20and%20bed%20nucleus%20of%20the%20stria%20terminalis%20in%20the%20behavioral,%20pain%20modulatory,%20and%20endocrine%20consequences%20of%20opiate%20withdrawal&rft.jtitle=Neuroscience&rft.au=McNally,%20G.P&rft.date=2002-01-01&rft.volume=112&rft.issue=3&rft.spage=605&rft.epage=617&rft.pages=605-617&rft.issn=0306-4522&rft.eissn=1873-7544&rft.coden=NRSCDN&rft_id=info:doi/10.1016/S0306-4522(02)00105-7&rft_dat=%3Cproquest_cross%3E18473271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18473271&rft_id=info:pmid/12074902&rft_els_id=S0306452202001057&rfr_iscdi=true